Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

231 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Optimal dose of intravenous cyclophosphamide during remission induction therapy in ANCA-associated vasculitis: A retrospective cohort study of J-CANVAS.
Sofue H, Kida T, Hirano A, Omura S, Kadoya M, Nakagomi D, Abe Y, Takizawa N, Nomura A, Kukida Y, Kondo N, Yamano Y, Yanagida T, Endo K, Hirata S, Matsui K, Takeuchi T, Ichinose K, Kato M, Yanai R, Matsuo Y, Shimojima Y, Nishioka R, Okazaki R, Takata T, Ito T, Moriyama M, Takatani A, Miyawaki Y, Ito-Ihara T, Yajima N, Kawaguchi T, Fujioka K, Fujii W, Seno T, Wada M, Kohno M, Kawahito Y. Sofue H, et al. Among authors: miyawaki y. Mod Rheumatol. 2024 Jul 6;34(4):767-774. doi: 10.1093/mr/road099. Mod Rheumatol. 2024. PMID: 37801552
Prognostic factors of methotrexate-associated lymphoproliferative disorders associated with rheumatoid arthritis and plausible application of biological agents.
Katsuyama T, Sada KE, Yan M, Zeggar S, Hiramatsu S, Miyawaki Y, Ohashi K, Morishita M, Watanabe H, Katsuyama E, Takano-Narazaki M, Toyota-Tatebe N, Sunahori-Watanabe K, Kawabata T, Miyake K, Kiguchi T, Wada J. Katsuyama T, et al. Among authors: miyawaki y. Mod Rheumatol. 2017 Sep;27(5):773-777. doi: 10.1080/14397595.2016.1259714. Epub 2016 Dec 15. Mod Rheumatol. 2017. PMID: 27846761
Anti-SS-A/Ro antibody positivity as a risk factor for relapse in patients with polymyositis/dermatomyositis.
Tatebe N, Sada KE, Asano Y, Zeggar S, Hiramatsu S, Miyawaki Y, Ohashi K, Morishita M, Katsuyama T, Katsuyama E, Watanabe H, Narazaki M, Watanabe K, Kawabata T, Wada J. Tatebe N, et al. Among authors: miyawaki y. Mod Rheumatol. 2018 Jan;28(1):141-146. doi: 10.1080/14397595.2017.1317377. Epub 2017 May 2. Mod Rheumatol. 2018. PMID: 28463039 Free article.
Risk Factors for Chronic Damage Accumulation Across Different Onset Eras in Systemic Lupus Erythematosus: A Cross-sectional Analysis of a Lupus Registry of Nationwide Institutions (LUNA).
Ohashi K, Sada KE, Asano Y, Hayashi K, Yamamura Y, Asano SH, Miyawaki Y, Morishita M, Katsuyama E, Watanabe H, Tatebe N, Narazaki M, Matsumoto Y, Sunahori-Watanabe K, Kawabata T, Yajima N, Wada J. Ohashi K, et al. Among authors: miyawaki y. Acta Med Okayama. 2020 Jun;74(3):191-198. doi: 10.18926/AMO/59949. Acta Med Okayama. 2020. PMID: 32577016 Free article.
Simultaneous development of IgA vasculitis and eosinophilic granulomatosis with polyangiitis.
Asano Y, Matsumoto Y, Miyazaki T, Ishizu A, Morizane S, Hayashi K, Yamamura Y, Hiramatsu S, Miyawaki Y, Morishita M, Ohashi K, Watanabe H, Watanabe KS, Kawabata T, Sada KE, Makino H, Wada J. Asano Y, et al. Among authors: miyawaki y. Mod Rheumatol Case Rep. 2020 Jan;4(1):63-69. doi: 10.1080/24725625.2019.1673528. Epub 2019 Oct 23. Mod Rheumatol Case Rep. 2020. PMID: 33086980
Association of glucocorticoid doses and emotional health in lupus low disease activity state (LLDAS): a cross-sectional study.
Miyawaki Y, Shimizu S, Ogawa Y, Sada KE, Katayama Y, Asano Y, Hayashi K, Yamamura Y, Hiramatsu-Asano S, Ohashi K, Morishita M, Watanabe H, Takano-Narazaki M, Matsumoto Y, Yajima N, Yoshimi R, Shimojima Y, Ohno S, Kajiyama H, Ichinose K, Sato S, Fujiwara M, Yamazaki H, Yamamoto Y, Wada J, Fukuhara S. Miyawaki Y, et al. Arthritis Res Ther. 2021 Mar 10;23(1):79. doi: 10.1186/s13075-021-02466-2. Arthritis Res Ther. 2021. PMID: 33691746 Free PMC article.
Real-world data on vitamin D supplementation and its impacts in systemic lupus erythematosus: Cross-sectional analysis of a lupus registry of nationwide institutions (LUNA).
Hayashi K, Sada KE, Asano Y, Katayama Y, Ohashi K, Morishita M, Miyawaki Y, Watanabe H, Katsuyama T, Narazaki M, Matsumoto Y, Yajima N, Yoshimi R, Shimojima Y, Ohno S, Kajiyama H, Ichinose K, Sato S, Fujiwara M, Wada J. Hayashi K, et al. Among authors: miyawaki y. PLoS One. 2022 Jun 29;17(6):e0270569. doi: 10.1371/journal.pone.0270569. eCollection 2022. PLoS One. 2022. PMID: 35767524 Free PMC article.
Hypertrophic pachymeningitis in ANCA-associated vasculitis: a cross-sectional and multi-institutional study in Japan (J-CANVAS).
Shimojima Y, Kishida D, Ichikawa T, Kida T, Yajima N, Omura S, Nakagomi D, Abe Y, Kadoya M, Takizawa N, Nomura A, Kukida Y, Kondo N, Yamano Y, Yanagida T, Endo K, Hirata S, Matsui K, Takeuchi T, Ichinose K, Kato M, Yanai R, Matsuo Y, Nishioka R, Okazaki R, Takata T, Ito T, Moriyama M, Takatani A, Miyawaki Y, Ito-Ihara T, Kawaguchi T, Kawahito Y, Sekijima Y. Shimojima Y, et al. Among authors: miyawaki y. Arthritis Res Ther. 2022 Aug 23;24(1):204. doi: 10.1186/s13075-022-02898-4. Arthritis Res Ther. 2022. PMID: 35999568 Free PMC article.
Association of one-point glucocorticoid-free status with chronic damage and disease duration in systemic lupus erythematosus: a cross-sectional study.
Sada KE, Katayama Y, Asano Y, Hayashi K, Miyawaki Y, Ohashi K, Katsuyama E, Katsuyama T, Takano-Narazaki M, Matsumoto Y, Yoshimi R, Shimojima Y, Ohno S, Kajiyama H, Ichinose K, Sato S, Fujiwara M, Yajima N. Sada KE, et al. Among authors: miyawaki y. Lupus Sci Med. 2022 Sep;9(1):e000772. doi: 10.1136/lupus-2022-000772. Lupus Sci Med. 2022. PMID: 36167483 Free PMC article.
231 results